Company · CIK 0001826457 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Monte Rosa Therapeutics, Inc. · GLUE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 SForm 4 → | Jul 17, 4:05 pm EDT | Markus WarmuthPresident & CEO, Director | 9,500 | $23.18 | $220,219 | 585,038 | −1.60% | |
| Jul 15, 2026 SForm 4 → | Jul 16, 4:10 pm EDT | Jennifer ChampouxChief Operating Officer | 4,351 | $23.38 | $101,730 | 62,371 | −6.52% | 10b5-1 |
| Jul 15, 2026 MForm 4 → | Jul 16, 4:10 pm EDT | Jennifer ChampouxChief Operating Officer | 4,351 | $3.98 | $17,317 | 66,722 | — | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 7, 4:41 pm EDT | Sharon TownsonChief Scientific Officer | 6,000 | $23.31 | $139,849 | 67,845 | −8.13% | 10b5-1 |
| Jul 6, 2026 MForm 4 → | Jul 7, 4:41 pm EDT | Sharon TownsonChief Scientific Officer | 6,000 | $6.14 | $36,840 | 73,845 | — | 10b5-1 |
| Jul 1, 2026 JForm 4 → | Jul 6, 5:57 pm EDT | Ali BehbahaniDirector | 1,030,000 | — | — | 0 | — | |
| Jun 30, 2026 SForm 4 → | Jul 1, 4:57 pm EDT | Filip JankuChief Medical Officer | 5,407 | $24.50 | $132,472 | 60,612 | −8.19% | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 1, 4:57 pm EDT | Filip JankuChief Medical Officer | 5,407 | $13.41 | $72,508 | 66,019 | — | 10b5-1 |
| Jun 29, 2026 SForm 4 → | Jun 30, 4:05 pm EDT | Filip JankuChief Medical Officer | 6,000 | $22.95 | $137,700 | 59,992 | −9.09% | 10b5-1 |
| Jun 29, 2026 MForm 4 → | Jun 30, 4:05 pm EDT | Filip JankuChief Medical Officer | 6,000 | $7.56 | $45,360 | 65,992 | — | 10b5-1 |
| Jun 29, 2026 SForm 4 → | Jun 30, 4:05 pm EDT | Anthony M. ManningDirector | 10,000 | $23.11 | $231,100 | 0 | −100% | |
| Jun 29, 2026 MForm 4 → | Jun 30, 4:05 pm EDT | Anthony M. ManningDirector | 10,000 | $4.16 | $41,600 | 10,000 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 MForm 4 → | Jul 16, 4:10 pm EDT | Jennifer ChampouxChief Operating Officer | 4,351 | — | — | 26,947 | — | 10b5-1 |
| Jul 6, 2026 MForm 4 → | Jul 7, 4:41 pm EDT | Sharon TownsonChief Scientific Officer | 6,000 | — | — | 197,290 | — | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 1, 4:57 pm EDT | Filip JankuChief Medical Officer | 5,407 | — | — | 81,093 | — | 10b5-1 |
| Jun 29, 2026 MForm 4 → | Jun 30, 4:05 pm EDT | Filip JankuChief Medical Officer | 6,000 | — | — | 60,000 | — | 10b5-1 |
| Jun 29, 2026 MForm 4 → | Jun 30, 4:05 pm EDT | Anthony M. ManningDirector | 10,000 | — | — | 2,100 | — |